Form 4: Adaptive Biotechnologies CEO Chad Robins Reports Stock Transactions
SEC Form 4 Filing
Chad Robins, CEO and Chairman of Adaptive Biotechnologies, reports the acquisition and disposal of common stock related to RSU vesting and tax obligations.
Summary
- On March 4, 2025, Chad Robins acquired 355,000 shares of Adaptive Biotechnologies common stock.
- On March 5, 2025, he sold 81,206 shares at $6.98 and 36,145 shares at $6.99.
- Also on March 5, 2025, he acquired 247,117 shares related to performance share units.
- On March 6, 2025, he sold 102,218 shares at $7.64.
- Following these transactions, Robins beneficially owns 2,959,249 shares of common stock.
- The sales on March 5 and 6 were to cover tax withholding obligations related to the vesting of RSUs and performance share units, as mandated by the issuer's equity incentive plans.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, as it simply reports facts.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. These filings are closely watched by investors as they can provide insights into management's perspective on the company's stock and future prospects.
Stakeholder Impact
- Shareholders may be interested in the trading activity of the CEO, as it can reflect his confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Acquisition of 355,000 shares of common stock. |
| 03/05/2025 | Sales of 81,206 shares at $6.98 and 36,145 shares at $6.99; acquisition of 247,117 performance share units; issuer certified achievement of performance goals; performance share units vested. |
| 03/06/2025 | Sale of 102,218 shares at $7.64. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.